240 related articles for article (PubMed ID: 32505995)
21. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic Particle Engineering of Hydrophobic Drug with Eudragit E100─Bridging the Amorphous and Crystalline Gap.
Shikha S; Lee YW; Doyle PS; Khan SA
Mol Pharm; 2022 Nov; 19(11):4345-4356. PubMed ID: 36268657
[TBL] [Abstract][Full Text] [Related]
23. In Vitro and In Vivo Characterization of Drug Nanoparticles Prepared Using PureNano™ Continuous Crystallizer to Improve the Bioavailability of Poorly Water Soluble Drugs.
Tahara K; Nishikawa M; Matsui K; Hisazumi K; Onodera R; Tozuka Y; Takeuchi H
Pharm Res; 2016 Sep; 33(9):2259-68. PubMed ID: 27301372
[TBL] [Abstract][Full Text] [Related]
24. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization.
Chow SF; Wan KY; Cheng KK; Wong KW; Sun CC; Baum L; Chow AH
Eur J Pharm Biopharm; 2015 Aug; 94():436-49. PubMed ID: 26143368
[TBL] [Abstract][Full Text] [Related]
25. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
26. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
[TBL] [Abstract][Full Text] [Related]
27. Microcrystalline cellulose-carboxymethyl cellulose sodium as an effective dispersant for drug nanocrystals: A case study.
Dan J; Ma Y; Yue P; Xie Y; Zheng Q; Hu P; Zhu W; Yang M
Carbohydr Polym; 2016 Jan; 136():499-506. PubMed ID: 26572381
[TBL] [Abstract][Full Text] [Related]
28. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
Bochmann ES; Neumann D; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
[TBL] [Abstract][Full Text] [Related]
29. Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension.
Šimková K; Joost B; Imanidis G
Eur J Pharm Biopharm; 2020 Jan; 146():19-31. PubMed ID: 31734282
[TBL] [Abstract][Full Text] [Related]
30. Interpreting
Rudd ND; Reibarkh M; Fang R; Mittal S; Walsh PL; Brunskill APJ; Forrest WP
Mol Pharm; 2020 May; 17(5):1734-1747. PubMed ID: 32267708
[TBL] [Abstract][Full Text] [Related]
31. Continuous production of aqueous suspensions of ultra-fine particles of curcumin using ultrasonically driven mixing device.
Pandey K; Chatte A; Dalvi S
Pharm Dev Technol; 2018 Jul; 23(6):608-619. PubMed ID: 28368746
[TBL] [Abstract][Full Text] [Related]
32. Nanonization of curcumin by antisolvent precipitation: process development, characterization, freeze drying and stability performance.
Yadav D; Kumar N
Int J Pharm; 2014 Dec; 477(1-2):564-77. PubMed ID: 25445971
[TBL] [Abstract][Full Text] [Related]
33. Poorly water-soluble drug nanoparticles via solvent evaporation in water-soluble porous polymers.
Roberts AD; Zhang H
Int J Pharm; 2013 Apr; 447(1-2):241-50. PubMed ID: 23499755
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Krull SM; Ma Z; Li M; Davé RN; Bilgili E
Drug Dev Ind Pharm; 2016; 42(7):1073-85. PubMed ID: 26567632
[TBL] [Abstract][Full Text] [Related]
35. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
Lim LM; Hadinoto K
Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
[TBL] [Abstract][Full Text] [Related]
37. Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
Meruva S; Thool P; Gong Y; Karki S; Bowen W; Kumar S
Int J Pharm; 2020 Mar; 577():119026. PubMed ID: 31940456
[TBL] [Abstract][Full Text] [Related]
38. Enhancing the Kinetic Stability of Polymeric Nanomicelles (PLGA) Using Nano-Montmorillonite for Effective Targeting of Cancer Tumors.
Karataş D; Bahadori F; Tekin A; Ergin Kizilcay G; Celik MS
J Phys Chem B; 2022 Jan; 126(2):463-479. PubMed ID: 35005971
[TBL] [Abstract][Full Text] [Related]
39. Exploring the feasibility of the use of biopolymers as a carrier in the formulation of amorphous solid dispersions - Part I: Gelatin.
Pas T; Vergauwen B; Van den Mooter G
Int J Pharm; 2018 Jan; 535(1-2):47-58. PubMed ID: 29097142
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of intravenously injectable curcumin nanosuspension.
Gao Y; Li Z; Sun M; Guo C; Yu A; Xi Y; Cui J; Lou H; Zhai G
Drug Deliv; 2011 Feb; 18(2):131-42. PubMed ID: 20939679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
